German Consumer Goods Manufacturer Selects End-to-End AP Automation Solution from Top Image Systems
Dec 12, 2016 13:01 pm UTC| Business
TEL AVIV, Israel and COLOGNE, Germany, Dec. 12, 2016 -- Top Image Systems Ltd. (NASDAQ:TISA) a global innovator of intelligent content processing solutions, announced today that a mid-sized German consumer goods...
German Consumer Goods Manufacturer Selects End-to-End AP Automation Solution from Top Image Systems
Dec 12, 2016 13:01 pm UTC| Business
TEL AVIV, Israel and COLOGNE, Germany, Dec. 12, 2016 -- Top Image Systems Ltd. (NASDAQ:TISA) a global innovator of intelligent content processing solutions, announced today that a mid-sized German consumer goods...
Dec 12, 2016 13:01 pm UTC| Business
Thought to be autoimmune in nature, the multiple sclerosis (MS) inflammatory process is also consistent with an infectious disease; The CEASE-MS Phase IIa proof-of-concept (PoC), single-arm, open-label study was designed...
Raiffeisen Selects VASCO for Secure Online Banking Login and Transaction Signing
Dec 12, 2016 13:00 pm UTC| Business
OAKBROOK TERRACE, Ill. and ST. GALLEN, Switzerland, Dec. 12, 2016 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity,...
Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo
Dec 12, 2016 13:00 pm UTC| Business
NORTHVALE, N.J., Dec. 12, 2016 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that it has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration...
Global Power Provides Update on Restatement Process
Dec 12, 2016 13:00 pm UTC| Business
IRVING, Texas, Dec. 12, 2016 -- Global Power Equipment Group Inc. (OTC:GLPW) (“Global Power” or the “Company”) today announced that it no longer expects that it will become current with its Securities and Exchange...
Dec 12, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases,...